首页> 美国卫生研究院文献>Biochemical Journal >Fluorine compounds inhibit the conversion of active type-1 protein phosphatases into the ATPMg-dependent form.
【2h】

Fluorine compounds inhibit the conversion of active type-1 protein phosphatases into the ATPMg-dependent form.

机译:氟化合物抑制活性的1型蛋白磷酸酶转化为ATPMg依赖性形式。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The modulator protein slowly converts the glycogen-bound protein phosphatase from liver, as well as its catalytic subunit, into an inactive form that requires protein kinase FA and MgATP for reactivation. The inactivation process could be completely prevented by addition of either 0.3 mM-NaF or 0.3 mM-phenylmethanesulphonyl fluoride (PMSF). The effectiveness of the proteinase inhibitor was not due to production of free fluoride. With the catalytic subunit a half-maximal effect of either fluorine compound was obtained at 25-50 microM. 2. The inactivation process was instantaneously blocked by the addition of NaF or PMSF at any moment during the incubation of the catalytic subunit with modulator. This fluoride effect was reversible. It did not result from a decreased affinity of modulator for the catalytic subunit. The use of analogues of PMSF showed that the fluorine atom was essential, but structural aspects were also an important determinant. 3. The relative efficiency of fluorine compounds in preventing the inactivation of the catalytic subunit by modulator corresponded to their relative potency as inhibitors of the phosphorylase phosphatase activity, but the latter effect required at least 20-fold higher effector concentrations. Incubation of the catalytic subunit with 10 mM-PMSF or -NaF caused an irreversible inhibition of the enzyme. 4. It is possible to prepare stable complexes of catalytic subunit and modulator, either active or ATPMg-dependent. Both species displayed the same molecular size during gel filtration. The inactive complex could be reactivated by incubation with MgATP and protein kinase FA. NaF and PMSF increased the final extent of re-activation at limiting concentrations of the protein kinase.
机译:1.调节蛋白将肝脏的糖原结合蛋白磷酸酶及其催化亚基缓慢转化为无活性形式,需要蛋白激酶FA和MgATP进行重新激活。通过添加0.3 mM-NaF或0.3 mM-苯基甲烷磺酰氟(PMSF)可以完全防止失活过程。蛋白酶抑制剂的有效性不是由于游离氟化物的产生。使用催化亚基,在25-50 microM下获得了任何一种氟化合物的半数最大效应。 2.在催化亚基与调节剂一起孵育的任何时刻,通过添加NaF或PMSF瞬间阻止了失活过程。这种氟化物作用是可逆的。这不是由于调节剂对催化亚基的亲和力降低引起的。 PMSF类似物的使用表明氟原子是必不可少的,但结构方面也是一个重要的决定因素。 3.氟化合物防止通过调节剂使催化亚基失活的相对效率对应于它们作为磷酸化酶磷酸酶活性抑制剂的相对效力,但是后者的作用需要至少高20倍的效应子浓度。催化亚基与10 mM-PMSF或-NaF一起孵育会导致酶的不可逆抑制。 4.有可能制备活性或ATPMg依赖性的催化亚基和调节剂的稳定络合物。两种物质在凝胶过滤过程中均显示相同的分子大小。失活的复合物可以通过与MgATP和蛋白激酶FA孵育而重新激活。 NaF和PMSF在极限蛋白激酶浓度下增加了重新激活的最终程度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号